Genome-wide association study of perioperative myocardial infarction after coronary artery bypass surgery.
dc.contributor.author | Kertai, Miklos D | |
dc.contributor.author | Li, Yi-Ju | |
dc.contributor.author | Li, Yen-Wei | |
dc.contributor.author | Ji, Yunqi | |
dc.contributor.author | Alexander, John | |
dc.contributor.author | Newman, Mark F | |
dc.contributor.author | Smith, Peter K | |
dc.contributor.author | Joseph, Diane | |
dc.contributor.author | Mathew, Joseph P | |
dc.contributor.author | Podgoreanu, Mihai V | |
dc.contributor.author | Duke Perioperative Genetics and Safety Outcomes (PEGASUS) Investigative Team | |
dc.coverage.spatial | England | |
dc.date.accessioned | 2015-12-05T21:05:18Z | |
dc.date.issued | 2015-05-06 | |
dc.description.abstract | OBJECTIVES: Identification of patient subpopulations susceptible to develop myocardial infarction (MI) or, conversely, those displaying either intrinsic cardioprotective phenotypes or highly responsive to protective interventions remain high-priority knowledge gaps. We sought to identify novel common genetic variants associated with perioperative MI in patients undergoing coronary artery bypass grafting using genome-wide association methodology. SETTING: 107 secondary and tertiary cardiac surgery centres across the USA. PARTICIPANTS: We conducted a stage I genome-wide association study (GWAS) in 1433 ethnically diverse patients of both genders (112 cases/1321 controls) from the Genetics of Myocardial Adverse Outcomes and Graft Failure (GeneMAGIC) study, and a stage II analysis in an expanded population of 2055 patients (225 cases/1830 controls) combined from the GeneMAGIC and Duke Perioperative Genetics and Safety Outcomes (PEGASUS) studies. Patients undergoing primary non-emergent coronary bypass grafting were included. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome variable was perioperative MI, defined as creatine kinase MB isoenzyme (CK-MB) values ≥10× upper limit of normal during the first postoperative day, and not attributable to preoperative MI. Secondary outcomes included postoperative CK-MB as a quantitative trait, or a dichotomised phenotype based on extreme quartiles of the CK-MB distribution. RESULTS: Following quality control and adjustment for clinical covariates, we identified 521 single nucleotide polymorphisms in the stage I GWAS analysis. Among these, 8 common variants in 3 genes or intergenic regions met p<10(-5) in stage II. A secondary analysis using CK-MB as a quantitative trait (minimum p=1.26×10(-3) for rs609418), or a dichotomised phenotype based on extreme CK-MB values (minimum p=7.72×10(-6) for rs4834703) supported these findings. Pathway analysis revealed that genes harbouring top-scoring variants cluster in pathways of biological relevance to extracellular matrix remodelling, endoplasmic reticulum-to-Golgi transport and inflammation. CONCLUSIONS: Using a two-stage GWAS and pathway analysis, we identified and prioritised several potential susceptibility loci for perioperative MI. | |
dc.identifier | ||
dc.identifier | bmjopen-2014-006920 | |
dc.identifier.eissn | 2044-6055 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | BMJ | |
dc.relation.ispartof | BMJ Open | |
dc.relation.isversionof | 10.1136/bmjopen-2014-006920 | |
dc.subject | GENETICS | |
dc.subject | SURGERY | |
dc.subject | Adult | |
dc.subject | Aged | |
dc.subject | Biomarkers | |
dc.subject | Coronary Artery Bypass | |
dc.subject | Creatine Kinase | |
dc.subject | Female | |
dc.subject | Genome-Wide Association Study | |
dc.subject | Humans | |
dc.subject | Intraoperative Complications | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Monitoring, Physiologic | |
dc.subject | Myocardial Infarction | |
dc.subject | Myocardium | |
dc.subject | Prognosis | |
dc.title | Genome-wide association study of perioperative myocardial infarction after coronary artery bypass surgery. | |
dc.type | Journal article | |
duke.contributor.orcid | Li, Yi-Ju|0000-0001-6996-4834 | |
duke.contributor.orcid | Alexander, John|0000-0002-1444-2462 | |
duke.contributor.orcid | Mathew, Joseph P|0000-0002-3815-4131 | |
pubs.author-url | ||
pubs.begin-page | e006920 | |
pubs.issue | 5 | |
pubs.organisational-group | Anesthesiology | |
pubs.organisational-group | Anesthesiology, Cardiothoracic | |
pubs.organisational-group | Basic Science Departments | |
pubs.organisational-group | Biostatistics & Bioinformatics | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Duke | |
pubs.organisational-group | Duke Clinical Research Institute | |
pubs.organisational-group | Duke Molecular Physiology Institute | |
pubs.organisational-group | Institutes and Centers | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Medicine, Cardiology | |
pubs.organisational-group | School of Medicine | |
pubs.organisational-group | Surgery | |
pubs.organisational-group | Surgery, Cardiovascular and Thoracic Surgery | |
pubs.publication-status | Published online | |
pubs.volume | 5 |
Files
Original bundle
- Name:
- Genome-wide association study of perioperative myocardial infarction after coronary artery bypass surgery..pdf
- Size:
- 779.33 KB
- Format:
- Adobe Portable Document Format